Crossmark

Strategy for enhancing the therapeutic efficacy of histone deacetylase inhibitor dacinostat: the novel paradigm to tackle monotonous cancer chemoresistance

Crossref DOI link: https://doi.org/10.1007/s12272-015-0673-9

Published Online: 2015-10-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ganai, Shabir Ahmad
License Information

Text and Data Mining valid from 2015-10-19

Version of Record valid from 2015-10-19
More Information

Article History

Received: 12 August 2015

Accepted: 13 October 2015

First Online: 19 October 2015

Compliance with ethical standards

:

: The author declares that he has no conflict of interest with any author or funding agency.

Document is current

Any future updates will be listed below